Niagen Bioscience, Inc. (NAGE) Cash Flow Statement
Niagen Bioscience, Inc. (NAGE) generated $5.9M of operating cash flow over the twelve months to 2026-06-30, spent $275000 on capital expenditure and had free cash flow of $5.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NAGENiagen Bioscience, Inc.Follow NAGE — free
—
Price chart with a free account
- Market cap
- 192.3M
- P/E TTM
- 13.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -20.9 | -20.4 | -10.6 | -24.2 | -15.1 | 7.1 | 12.1 | 13.5 | 5.9 | |
| Capital expenditure | 1.3 | 0.7 | — | — | 0.3 | 0.1 | 0.2 | 0.3 | -0.3 | |
| Free cash flow | -22.2 | -21.2 | — | — | -15.4 | 7.0 | 11.9 | 13.2 | 5.7 | |
| Share repurchases | 0.4 | — | — | — | — | — | 0.0 | 0.3 | — | |
| Stock-based compensation | 6.4 | 7.2 | 6.9 | 6.2 | 5.7 | 4.8 | 3.7 | 6.1 | — |
USD millions · SEC XBRL
Niagen Bioscience, Inc. — questions
- What is Niagen Bioscience, Inc.'s operating cash flow?
- $5.9M over the twelve months to 2026-06-30.
- How much does Niagen Bioscience, Inc. spend on capital expenditure?
- $275000 over the twelve months to 2026-06-30.
- What is Niagen Bioscience, Inc.'s free cash flow?
- $5.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Niagen Bioscience, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.